You are here

Article Text

Article menu
Download PDFPDF
Articles
▼Perampanel: a new add-on treatment for epilepsy

Abstract

▼Perampanel (Fycompa – Eisai) is a new antiepileptic drug marketed in the EU. It is licensed for use as adjunctive treatment of partial-onset seizuresi with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.2 Here we discuss the place of perampanel in the treatment of epilepsy.

https://doi.org/10.1136/dtb.2013.1.0159

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text